INVIZA® Health—Powering Remote Monitoring™ via Inviza Intelligence

Background

INVIZA® Health, established in 2020, is a MedTech company headquartered in Cambridge, Massachusetts. The company specializes in developing self-charging, medical-grade wearable technologies aimed at enhancing remote patient monitoring (RPM) and digital therapeutics (DTx). Their flagship product, the INVIZA® CARE M1.0 platform, integrates smart insoles with advanced sensors and machine learning capabilities to provide real-time health data, thereby reducing hospital readmission rates and improving patient outcomes.

Key Strategic Focus

INVIZA® Health's strategic objectives include:

Healthcare Sector: Monitoring hospital personnel such as physicians, nurses, and respiratory therapists to promote preventative health measures. Expansion plans encompass in-hospital patients, hospital-at-home (HaH) patients, assisted living facilities, retirement communities, and VA hospitals.

Defense Sector: Enhancing health readiness and physical fitness monitoring within the military, specifically targeting the U.S. Air Force's Air Mobility Command (AMC) and other branches.

Financials and Funding

INVIZA® Health has secured significant funding to support its initiatives:

U.S. Air Force Contract: In June 2024, the company was awarded a $2.3 million contract by the SEMI Nano Bio Materials Consortium (NBMC) and the U.S. Air Force Research Laboratory (AFRL). This includes $1 million in non-dilutive AFRL funds, $550,000 from partner companies, and $750,000 in angel investment.

Seed Funding: The company is seeking $4 million in seed funding, reduced from an initial $5 million due to the aforementioned contract. The funds are allocated as follows:

Software Development: $1.6 million (40%)

Business Development, Marketing, and Sales: $1 million (25%)

Hardware Development: $500,000 (12.5%)

Manufacturing/Assembly/Test: $415,000 (10.4%)

Overhead: $190,000 (4.8%)

Intellectual Property: $150,000 (3.8%)

Customer Support: $75,000 (1.9%)

IT Support: $65,000 (1.6%)

Pipeline Development

INVIZA® Health's product pipeline includes:

INVIZA® CARE M1.0 Platform: Comprising self-charging smart insoles, a patient mobile app with DTx, a secure cloud platform, and a clinical dashboard. The platform is designed for both healthcare and defense applications, with ongoing enhancements such as integrating machine learning algorithms for real-time data processing.

Technological Platform and Innovation

INVIZA® Health's technological innovations include:

Self-Charging Smart Insoles: Utilizing piezoelectric energy harvesting, these insoles convert the user's steps into electricity, eliminating the need for manual recharging.

Advanced Sensor Integration: The insoles are equipped with medical-grade optical sensors capable of measuring heart rate, heart rate variability, respiratory rate, blood oxygen saturation (SpO2), body temperature, and body movements, including fall detection.

Machine Learning and AI: Integration of machine learning algorithms within the insoles' electronics enables real-time, on-device processing of health data, enhancing accuracy and reducing power consumption.

Leadership Team

Robert Andosca, Ph.D.: Co-founder, CEO, and CTO. With over 35 years in IoT, MEMS/sensors, and semiconductor industries, Dr. Andosca leads INVIZA® Health's strategic vision and technological development.

Qaizar Hassonjee, Ph.D.: Board Chair and Chief Visionary Strategist. Former VP of Innovations at Adidas and co-founder of Textronics, Dr. Hassonjee brings extensive experience in wearable technology and strategic growth.

Governor Dr. Jeffery Colyer, M.D.: Board Director and Chief Medical Strategist. Dr. Colyer provides medical expertise and strategic guidance, leveraging his background in healthcare and public service.

Leadership Changes

As of the latest available information, there have been no recent significant changes or appointments within the company's leadership team.

Competitor Profile

Market Insights and Dynamics

The global healthcare wearable devices market is experiencing rapid growth, driven by increasing demand for remote patient monitoring and digital health solutions. The integration of AI and machine learning in wearable devices is enhancing their capabilities, leading to improved patient outcomes and operational efficiencies.

Competitor Analysis

Key competitors in the wearable health monitoring space include:

Fitbit (acquired by Google): Offers a range of fitness trackers and smartwatches with health monitoring features. While popular among consumers, their devices may lack the medical-grade accuracy required for clinical applications.

Apple: The Apple Watch includes health monitoring features such as ECG and blood oxygen measurement. However, it requires regular charging and may not offer the same level of integration with healthcare providers as INVIZA® Health's platform.

Garmin: Provides fitness wearables with health tracking capabilities. Similar to other consumer-focused devices, they may not meet the stringent requirements of medical-grade monitoring.

Strategic Collaborations and Partnerships

INVIZA® Health has established significant collaborations to enhance its technological capabilities:

U.S. Air Force Research Laboratory (AFRL): The $2.3 million contract supports the development of advanced RPM technologies with integrated machine learning for military applications.

Quanterion Solutions, GP Plasma, Light-It, and the University of Utah: These partnerships aim to further enhance the INVIZA® CARE M1.0 platform's capabilities, particularly in energy harvesting and sensor integration.

Operational Insights

INVIZA® Health's strategic positioning includes:

Product Differentiation: The self-charging capability of their smart insoles addresses a common pain point in wearable technology—battery life—thereby enhancing user compliance and data accuracy.

Regulatory Compliance: The company's products are designed to meet regulatory standards, including RoHS compliance, facilitating market entry in regions with strict environmental regulations.

Strategic Opportunities and Future Directions

INVIZA® Health's future strategies encompass:

Market Expansion: Targeting additional sectors within healthcare and defense, including assisted living facilities, retirement communities, and various military branches.

Technological Advancements: Continued integration of advanced machine learning algorithms and AI to enhance the predictive capabilities of their monitoring platforms.